Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
C Maya

Single-pill strategy to beat cardiovascular diseases gets WHO recognition

Last week, in a major policy change, the WHO included three fixed dose combinations of cardiovascular medicines or polypills on its revised Model Lists of Essential Medicines (EML) 2023 for use in primary and secondary prevention of atherosclerotic cardiovascular diseases.

(For top health news of the day, subscribe to our newsletter Health Matters)

The WHO Expert Committee on Selection and Use of Essential Medicines noted the evidence from large randomised-controlled trials that the use of the polypill is associated with reduced risks of cardiovascular events, including fatal and non-fatal myocardial infarction and stroke, and the need for revascularisation in primary and secondary prevention settings.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.